Multiples PE, others pick up 9.3% stake in BDR Pharma for ₹685 crore

Published - May 17, 2022 09:55 pm IST - Mumbai

Multiples Private Equity has announced to lead an investment of ₹685 crore along with a few other financial investors for a 9.3% stake in BDR Pharmaceuticals International Pvt. Ltd., an R&D focused, integrated pharma player. 

The funds will be used by the company to build additional research and development capabilities in current and emerging areas, accelerate investments in manufacturing capacity expansion and enhance the degree of vertical integration. The company will also selectively pursue inorganic opportunities to build scale.

Dharmesh Shah, CMD, BDR Pharma said, “We are looking forward to accelerate our growth journey with trusted investors having a deep understanding of the sector and regulatory environment and who bring first-hand experience in working with innovative, high-growth companies.”

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.